Journal of Thyroid Disorders & Therapy
Open Access

Bolgov MY

Biography

Dr. Mikhail Y. Bolgov is a distinguished surgeon at the V.P. Komisarenko Institute of Endocrinology and Metabolism, part of the National Academy of Medical Sciences of Ukraine in Kyiv. His clinical expertise and research focus on endocrine surgery, particularly the management and treatment of thyroid and adrenal gland disorders. In 2018, Dr. Bolgov co-authored the study "Main Prognostic Factors for Well-Differentiated Thyroid Cancer: Analysis of Combined Patients' Treatment Results During 20 Years After Surgery," published in the Journal of Thyroid Disorders & Therapy. This extensive research analyzed long-term treatment outcomes of patients with well-differentiated thyroid cancer, identifying key prognostic factors that influence patient prognosis and informing surgical strategies. Dr. Bolgov also contributed to the 2017 case report "Pheochromoblastoma: Case of 19-Year Follow-Up Study," featured in Clinics in Surgery. This report detailed a prolonged follow-up of a patient with pheochromoblastoma, providing valuable insights into the long-term management and outcomes of this rare adrenal gland tumor. Through his clinical practice and research, Dr. Bolgov continues to advance the field of endocrine surgery, contributing to improved patient outcomes and a deeper understanding of endocrine disorders.

Publications

• Research Article
  Main Prognostic Factors for Well Differentiated Thyroid Cancer: Analis of Combined Patients Treatment Results during 20 Years after Surgery
  Author(s): Guda BB, Kovalenko AE, Bolgov MY, Taraschenko YM and Mykhailenko NIGuda BB, Kovalenko AE, Bolgov MY, Taraschenko YM and Mykhailenko NI
  
  Background: In general, the prognosis in patients with well differentiated thyroid carcinoma (WDTC) is excellent. However, there are small cohorts of patients who experience a more aggressive form of disease which is often associated with certain poor prognostic factors. Identifying these patients at an early stage is imperative for guiding treatment decisions. The purpose of the work is to study the cumulative survival of patients with WDTC, depending on a number of clinical and biological characteristics of tumors. Methods: A retrospective cohort study of patients operated on WDTC in the period from 1995 to 2015 (5526 people). Each patient was analyzed according to age, gender, tumor size and characteristics of the TNM (7 editions), clinical stage, volume of surgery, number of points on the MACIS scale, risk group, number of courses of rad.. View More»
  DOI: 10.4172/2167-7948.1000228

  Abstract PDF

Relevant Topics